TRIDENT LIFELINE
|
TRIDENT LIFELINE Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
Profit Before Tax | ₹8.70 Cr | ₹6.58 Cr | ₹2.98 Cr |
Adjustment | ₹0.12 Cr | ₹0.08 Cr | ₹0.33 Cr |
Changes In working Capital | ₹-4.20 Cr | ₹-25 Cr | ₹-3.67 Cr |
Cash Flow after changes in Working Capital | ₹4.61 Cr | ₹-18 Cr | ₹-0.36 Cr |
Cash Flow from Operating Activities | ₹2.23 Cr | ₹-19 Cr | ₹-0.21 Cr |
Cash Flow from Investing Activities | ₹-20 Cr | ₹-9.69 Cr | ₹-0.45 Cr |
Cash Flow from Financing Activities | ₹11 Cr | ₹42 Cr | ₹0.80 Cr |
Net Cash Inflow / Outflow | ₹-7.13 Cr | ₹14 Cr | ₹0.14 Cr |
Opening Cash & Cash Equivalents | ₹14 Cr | ₹0.18 Cr | ₹0.01 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - |
Closing Cash & Cash Equivalent | ₹6.65 Cr | ₹14 Cr | ₹0.16 Cr |
Compare Cashflow Statement of peers of TRIDENT LIFELINE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TRIDENT LIFELINE | ₹330.2 Cr | 3.7% | 1.1% | 69.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,519.0 Cr | 0.3% | -4.9% | 15.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,903.0 Cr | 0.2% | 10% | 53.5% | Stock Analytics | |
CIPLA | ₹121,669.0 Cr | 2.3% | 1.1% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,097.0 Cr | 5.7% | 15% | 11.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,605.0 Cr | 0.8% | -0.9% | 17.4% | Stock Analytics |
TRIDENT LIFELINE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TRIDENT LIFELINE | 3.7% |
1.1% |
69.5% |
SENSEX | 1.3% |
2.6% |
7.8% |
You may also like the below Video Courses